Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
Growth Factors (Chur, Switzerland)|May 10, 2002
Hierarchy of stroma-derived factors in supporting growth of stroma-dependent hemopoietic cells: membrane-bound SCF is sufficient to confer stroma competence to epithelial cellsJutta Friel, Katsuhiko Itoh, Ulla Bergholz, et al.
Biochemical and Biophysical Research Communications|February 2, 2020
Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1Nina Nelson, Torsten Wundenberg, Hongying Lin, et al.
Analytical Biochemistry|June 16, 2012
A toolkit for graded expression of green fluorescent protein fusion proteins in mammalian cellsMarcus M Nalaskowski, Patrick Ehm, Susanne Giehler, et al.
Biochimie|March 18, 2014
Efficacious inhibition of Importin α/β-mediated nuclear import of human inositol phosphate multikinaseInga Kublun, Patrick Ehm, Maria A Brehm, et al.
Plos One|May 4, 2016
Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor CellsMarina Holler, Astrid Grottke, Katharina Mueck, et al.
Molecular Cancer|November 22, 2012
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cellsNicole Grabinski, Florian Ewald, Bianca T Hofmann, et al.
Oncotarget|August 18, 2016
Akt isoform specific effects in ovarian cancer progressionNicolle M Linnerth-Petrik, Lisa A Santry, Roger Moorehead, et al.
British Journal of Haematology|December 15, 2005
Up-regulation of the T cell quiescence factor KLF2 in a leukaemic T-cell line after expression of the inositol 5'-phosphatase SHIP-1Lizet García-Palma, Stefan Horn, Friedrich Haag, et al.
Cellular Signalling|January 28, 2014
AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT miceNicole Grabinski, Katharina Möllmann, Karin Milde-Langosch, et al.
Pageof 8